The cryoablation devices market size has grown rapidly in recent years. It will grow from $0.61 billion in 2025 to $0.67 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rising incidence of cancer and cardiac arrhythmias, increasing adoption of minimally invasive treatment options, growth in interventional oncology procedures, expansion of cardiac electrophysiology services, improved clinical outcomes of cryoablation therapies.
The cryoablation devices market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing demand for organ-sparing cancer treatments, increasing preference for minimally invasive alternatives to surgery, rising adoption of ablation therapies in early-stage disease management, expansion of specialty treatment centers, continuous advancements in ablation probe and system design. Major trends in the forecast period include rising adoption of minimally invasive cryoablation procedures, increasing use of cryoablation in oncology and cardiology, growing preference for image-guided ablation techniques, expansion of outpatient and ambulatory cryoablation treatments, increasing demand for precision-controlled tissue ablation.
The growing prevalence of cardiovascular diseases is expected to drive the expansion of the cryoablation devices market in the coming years. Cardiovascular diseases (CVD) include a range of heart and blood vessel disorders, such as coronary artery disease, hypertension, heart failure, arrhythmias, and stroke. The rise in CVD cases is attributed to factors like aging populations, increasing obesity rates, and greater exposure to risk factors like smoking and pollution. Cryoablation devices are essential in cardiology for treating arrhythmias, such as atrial fibrillation, by creating controlled lesions in heart tissue to disrupt abnormal electrical pathways, helping restore normal heart rhythm and enhancing patient quality of life. For example, in February 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, Blackpool recorded 185 deaths from cardiovascular disease in 2023, compared to 178 deaths in 2022. As such, the rising prevalence of cardiovascular diseases is expected to fuel the growth of the cryoablation devices market.
Rising healthcare expenditure is expected to drive the growth of the cryoablation devices market in the coming years. Healthcare expenditure includes total spending on medical services, public health programs, and health-related goods aimed at maintaining or improving population health. The increase in healthcare spending is largely driven by the growing burden of chronic diseases, which require ongoing treatment, long-term medications, and frequent medical care. Higher healthcare expenditure enables hospitals to adopt cryoablation devices by investing in advanced minimally invasive treatment technologies, expanding procedural capacities, and improving patient access to modern therapeutic options. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, U.S. healthcare expenditures in 2023 rose by 7.5%, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, rising healthcare expenditure is supporting the expansion of the cryoablation devices market.
Leading companies in the cryoablation devices market are concentrating on the development of innovative products, such as cryoprobes, to improve the precision and effectiveness of treatments. A cryoprobe is a medical instrument used in cryotherapy, a procedure that applies extreme cold to tissue in order to treat conditions like tumors, lesions, or abnormal growths. For example, in May 2023, Varian, a U.S.-based medical device company and part of Siemens Healthineers, launched the Isolis cryoprobe. The Isolis cryoprobe is a single-use, disposable device designed to enhance precision and efficiency in cryoablation procedures, where tissue is carefully frozen to address conditions like tumors. It provides interventional radiologists with improved control through its sharp tip and optional integration with the Siemens Healthineers myNeedle Laser guidance system for precise probe placement.
Major companies operating in the cryoablation devices market are Medtronic plc, Boston Scientific Corporation, CooperSurgical Inc., MicroPort Scientific Corporation, AtriCure Inc., Vimecon GmbH, Erbe Elektromedizin GmbH, MedGyn Products Inc., HealthTronics Inc., METRUM CRYOFLEX Sp. z o.o., Adagio Medical Inc., Channel Medsystems Inc., CPSI Biotech, CryoTherapeutics GmbH, Endocare Inc., Galil Medical Ltd., Sanarus Technologies Inc., IceCure Medical Ltd., AngioDynamics Inc., CryoConcepts GmbH.
North America was the largest region in the cryoablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cryoablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cryoablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cryoablation devices market by increasing costs for imported cryoprobes, generators, gas cartridges, and precision-engineered components used in advanced ablation systems. These cost pressures have particularly affected integrated cryoablation systems and disposable consumables, with asia-pacific and europe experiencing higher exposure due to global sourcing dependencies. Increased tariffs have raised capital and procedural costs for hospitals and specialty centers. However, tariffs have also encouraged local manufacturing, component localization, and regional supply chain diversification, supporting long-term market resilience.
The cryoablation devices market research report is one of a series of new reports that provides cryoablation devices market statistics, including cryoablation devices industry global market size, regional shares, competitors with a cryoablation devices market share, detailed cryoablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the cryoablation devices industry. This cryoablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cryoablation devices are specialized medical tools utilized for cryoablation procedures, which involve using extreme cold to eliminate abnormal tissues such as tumors or malfunctioning heart tissue. These devices are pivotal in modern medicine, offering a minimally invasive method for treating specific medical conditions by freezing targeted tissues under controlled conditions.
There are several types of cryoablation devices, including probes, tissue contact probe ablators, epidermal and subcutaneous cryoablation systems, generators, and associated accessories and consumables. The design and configuration of the cryoablation probe, categorized by probe type, are crucial in enhancing the effectiveness, safety, and precision of cryoablation procedures across various medical disciplines. Cryoablation finds applications in cardiology, oncology, and other medical fields, serving diverse end-users such as hospitals, ambulatory surgical centers, and specialty clinics.
The cryoablation devices market consists of sales general cryoprobes, cryogen delivery systems, cryoablation consoles, imaging guidance systems, and portable cryoablation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cryoablation devices market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing demand for organ-sparing cancer treatments, increasing preference for minimally invasive alternatives to surgery, rising adoption of ablation therapies in early-stage disease management, expansion of specialty treatment centers, continuous advancements in ablation probe and system design. Major trends in the forecast period include rising adoption of minimally invasive cryoablation procedures, increasing use of cryoablation in oncology and cardiology, growing preference for image-guided ablation techniques, expansion of outpatient and ambulatory cryoablation treatments, increasing demand for precision-controlled tissue ablation.
The growing prevalence of cardiovascular diseases is expected to drive the expansion of the cryoablation devices market in the coming years. Cardiovascular diseases (CVD) include a range of heart and blood vessel disorders, such as coronary artery disease, hypertension, heart failure, arrhythmias, and stroke. The rise in CVD cases is attributed to factors like aging populations, increasing obesity rates, and greater exposure to risk factors like smoking and pollution. Cryoablation devices are essential in cardiology for treating arrhythmias, such as atrial fibrillation, by creating controlled lesions in heart tissue to disrupt abnormal electrical pathways, helping restore normal heart rhythm and enhancing patient quality of life. For example, in February 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, Blackpool recorded 185 deaths from cardiovascular disease in 2023, compared to 178 deaths in 2022. As such, the rising prevalence of cardiovascular diseases is expected to fuel the growth of the cryoablation devices market.
Rising healthcare expenditure is expected to drive the growth of the cryoablation devices market in the coming years. Healthcare expenditure includes total spending on medical services, public health programs, and health-related goods aimed at maintaining or improving population health. The increase in healthcare spending is largely driven by the growing burden of chronic diseases, which require ongoing treatment, long-term medications, and frequent medical care. Higher healthcare expenditure enables hospitals to adopt cryoablation devices by investing in advanced minimally invasive treatment technologies, expanding procedural capacities, and improving patient access to modern therapeutic options. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, U.S. healthcare expenditures in 2023 rose by 7.5%, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, rising healthcare expenditure is supporting the expansion of the cryoablation devices market.
Leading companies in the cryoablation devices market are concentrating on the development of innovative products, such as cryoprobes, to improve the precision and effectiveness of treatments. A cryoprobe is a medical instrument used in cryotherapy, a procedure that applies extreme cold to tissue in order to treat conditions like tumors, lesions, or abnormal growths. For example, in May 2023, Varian, a U.S.-based medical device company and part of Siemens Healthineers, launched the Isolis cryoprobe. The Isolis cryoprobe is a single-use, disposable device designed to enhance precision and efficiency in cryoablation procedures, where tissue is carefully frozen to address conditions like tumors. It provides interventional radiologists with improved control through its sharp tip and optional integration with the Siemens Healthineers myNeedle Laser guidance system for precise probe placement.
Major companies operating in the cryoablation devices market are Medtronic plc, Boston Scientific Corporation, CooperSurgical Inc., MicroPort Scientific Corporation, AtriCure Inc., Vimecon GmbH, Erbe Elektromedizin GmbH, MedGyn Products Inc., HealthTronics Inc., METRUM CRYOFLEX Sp. z o.o., Adagio Medical Inc., Channel Medsystems Inc., CPSI Biotech, CryoTherapeutics GmbH, Endocare Inc., Galil Medical Ltd., Sanarus Technologies Inc., IceCure Medical Ltd., AngioDynamics Inc., CryoConcepts GmbH.
North America was the largest region in the cryoablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cryoablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cryoablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cryoablation devices market by increasing costs for imported cryoprobes, generators, gas cartridges, and precision-engineered components used in advanced ablation systems. These cost pressures have particularly affected integrated cryoablation systems and disposable consumables, with asia-pacific and europe experiencing higher exposure due to global sourcing dependencies. Increased tariffs have raised capital and procedural costs for hospitals and specialty centers. However, tariffs have also encouraged local manufacturing, component localization, and regional supply chain diversification, supporting long-term market resilience.
The cryoablation devices market research report is one of a series of new reports that provides cryoablation devices market statistics, including cryoablation devices industry global market size, regional shares, competitors with a cryoablation devices market share, detailed cryoablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the cryoablation devices industry. This cryoablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cryoablation devices are specialized medical tools utilized for cryoablation procedures, which involve using extreme cold to eliminate abnormal tissues such as tumors or malfunctioning heart tissue. These devices are pivotal in modern medicine, offering a minimally invasive method for treating specific medical conditions by freezing targeted tissues under controlled conditions.
There are several types of cryoablation devices, including probes, tissue contact probe ablators, epidermal and subcutaneous cryoablation systems, generators, and associated accessories and consumables. The design and configuration of the cryoablation probe, categorized by probe type, are crucial in enhancing the effectiveness, safety, and precision of cryoablation procedures across various medical disciplines. Cryoablation finds applications in cardiology, oncology, and other medical fields, serving diverse end-users such as hospitals, ambulatory surgical centers, and specialty clinics.
The cryoablation devices market consists of sales general cryoprobes, cryogen delivery systems, cryoablation consoles, imaging guidance systems, and portable cryoablation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cryoablation Devices Market Characteristics
3. Cryoablation Devices Market Supply Chain Analysis
4. Global Cryoablation Devices Market Trends and Strategies
5. Cryoablation Devices Market Analysis of End Use Industries
7. Global Cryoablation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cryoablation Devices Total Addressable Market (TAM) Analysis for the Market
9. Cryoablation Devices Market Segmentation
10. Cryoablation Devices Market Regional and Country Analysis
11. Asia-Pacific Cryoablation Devices Market
12. China Cryoablation Devices Market
13. India Cryoablation Devices Market
14. Japan Cryoablation Devices Market
15. Australia Cryoablation Devices Market
16. Indonesia Cryoablation Devices Market
17. South Korea Cryoablation Devices Market
18. Taiwan Cryoablation Devices Market
19. South East Asia Cryoablation Devices Market
20. Western Europe Cryoablation Devices Market
21. UK Cryoablation Devices Market
22. Germany Cryoablation Devices Market
23. France Cryoablation Devices Market
24. Italy Cryoablation Devices Market
25. Spain Cryoablation Devices Market
26. Eastern Europe Cryoablation Devices Market
27. Russia Cryoablation Devices Market
28. North America Cryoablation Devices Market
29. USA Cryoablation Devices Market
30. Canada Cryoablation Devices Market
31. South America Cryoablation Devices Market
32. Brazil Cryoablation Devices Market
33. Middle East Cryoablation Devices Market
34. Africa Cryoablation Devices Market
36. Cryoablation Devices Market Competitive Landscape and Company Profiles
37. Cryoablation Devices Market Other Major and Innovative Companies
40. Cryoablation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Cryoablation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cryoablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cryoablation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cryoablation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Probe; Tissue Contact Probe Ablators; Epidermal And Subcutaneous Cryoablation Systems; Systems; Generator; Accessories And consumables2) By Application: Cardiology; Oncology; Other Applications
3) By End-Use: Hospitals; Ambulatory Surgical Centers; Specialty Centers; Other End-Users
Subsegments:
1) By Probe: Cryoprobes; Thermal Probes; Radiofrequency Probes2) By Tissue Contact Probe Ablators: Microwave Ablators; RF Ablators; Ultrasound Ablators
3) By Epidermal and Subcutaneous Cryoablation Systems: Spray-Based Systems; Contact-Based Systems
4) By Systems: Standalone Systems; Integrated Systems
5) By Generator: High-Frequency Generators; Low-Frequency Generators
6) By Accessories and Consumables: Needles; Catheters; Gas Cartridges; Cooling Agents
Companies Mentioned: Medtronic plc; Boston Scientific Corporation; CooperSurgical Inc.; MicroPort Scientific Corporation; AtriCure Inc.; Vimecon GmbH; Erbe Elektromedizin GmbH; MedGyn Products Inc.; HealthTronics Inc.; METRUM CRYOFLEX Sp. z o.o.; Adagio Medical Inc.; Channel Medsystems Inc.; CPSI Biotech; CryoTherapeutics GmbH; Endocare Inc.; Galil Medical Ltd.; Sanarus Technologies Inc.; IceCure Medical Ltd.; AngioDynamics Inc.; CryoConcepts GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cryoablation Devices market report include:- Medtronic plc
- Boston Scientific Corporation
- CooperSurgical Inc.
- MicroPort Scientific Corporation
- AtriCure Inc.
- Vimecon GmbH
- Erbe Elektromedizin GmbH
- MedGyn Products Inc.
- HealthTronics Inc.
- METRUM CRYOFLEX Sp. z o.o.
- Adagio Medical Inc.
- Channel Medsystems Inc.
- CPSI Biotech
- CryoTherapeutics GmbH
- Endocare Inc.
- Galil Medical Ltd.
- Sanarus Technologies Inc.
- IceCure Medical Ltd.
- AngioDynamics Inc.
- CryoConcepts GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.67 Billion |
| Forecasted Market Value ( USD | $ 0.96 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
